Reproductive function and risk for PCOS in women treated for bipolar disorder

• Published in: Bipolar disorders Vol. 7; no. 3; pp. 246 - 259
• Main Authors: Rasgon, Natalie L, Altshuler, Lori L, Fairbanks, Lynn, Elman, Shana, Bitran, Jose, Labarca, Rodrigo, Saad, Mohammed, Kupka, Ralph, Nolen, Willem A, Frye, Mark A, Suppes, Trisha, McElroy, Susan L, Keck Jr, Paul E, Leverich, Gabriele, Grunze, Heinz, Walden, Joerg, Post, Robert, Mintz, Jim
• Format: Journal Article
• Language: English
• Published: Oxford, UK Munksgaard International Publishers 01.06.2005
• Subjects: Adolescent; Adult; Antimanic Agents - adverse effects; Antimanic Agents - therapeutic use; bipolar disorder; Bipolar Disorder - drug therapy; Endocrine System Diseases - blood; Endocrine System Diseases - chemically induced; Female; hirsutism; Humans; menstrual abnormalities; Menstruation Disturbances - chemically induced; Menstruation Disturbances - physiopathology; Middle Aged; polycystic ovary syndrome; Polycystic Ovary Syndrome - chemically induced; Polycystic Ovary Syndrome - physiopathology; Risk; Surveys and Questionnaires; Valproic Acid - adverse effects; Valproic Acid - therapeutic use; weight gain; women

Introduction:  This study examined the reproductive function and prevalence of polycystic ovary syndrome (PCOS) in women with bipolar disorder taking antimanic medications. Method:  Women aged 18–45 treated for bipolar disorder and not taking steroid contraceptives were recruited to complete questio...